Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
TNXP on Nasdaq
Shares outstanding
13,418,426
Price per share
$18.22
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,742,667
Total reported value
$58,484,802
% of total 13F portfolios
0%
Share change
+1,384,168
Value change
+$19,804,484
Number of holders
68
Price from insider filings
$18.22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Point72 Asset Management, L.P. 9.2% $19,884,434 1,235,058 Point72 Asset Management, L.P. 29 Dec 2025
BlackRock, Inc. 6.7% -14% $13,348,524 +$2,726,362 854,579 +26% BlackRock, Inc. 31 Dec 2025
VANGUARD GROUP INC 5% -22% $10,521,710 +$1,822,042 673,605 +21% The Vanguard Group 31 Dec 2025

As of 31 Dec 2025, 68 institutional investors reported holding 3,742,667 shares of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP). This represents 28% of the company’s total 13,418,426 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) together control 27% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.6% 884,881 +30% 0% $13,821,842
VANGUARD GROUP INC 5% 673,605 +21% 0% $10,521,710
Point72 Asset Management, L.P. 4.6% 620,033 0.02% $9,684,915
GEODE CAPITAL MANAGEMENT, LLC 2% 271,904 +35% 0% $4,248,035
STATE STREET CORP 1.4% 191,855 +26% 0% $2,996,775
Balyasny Asset Management L.P. 1.4% 185,352 0.01% $2,895,199
NORTHERN TRUST CORP 1.3% 174,886 +3.1% 0% $2,731,719
Nuveen, LLC 0.7% 93,402 +508% 0% $1,458,939
UBS Group AG 0.68% 91,459 +77% 0% $1,428,590
Davidson Kempner Capital Management LP 0.67% 90,006 0.03% $1,405,894
MORGAN STANLEY 0.31% 42,038 +168% 0% $656,634
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.25% 33,404 +25% 0% $521,770
JANE STREET GROUP, LLC 0.23% 30,626 0% $478,378
BANK OF AMERICA CORP /DE/ 0.23% 30,314 +552% 0% $473,505
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.22% 29,662 +239% 0% $463,320
GOLDMAN SACHS GROUP INC 0.2% 26,808 +111% 0% $418,741
Bank of New York Mellon Corp 0.18% 24,064 +19% 0% $375,876
MILLENNIUM MANAGEMENT LLC 0.17% 22,946 -56% 0% $358,417
BARCLAYS PLC 0.17% 22,231 +78% 0% $347,249
AQR CAPITAL MANAGEMENT LLC 0.15% 20,020 0% $312,713
Man Group plc 0.14% 18,442 0% $288,064
WELLS FARGO & COMPANY/MN 0.11% 15,430 +115% 0% $241,016
Engineers Gate Manager LP 0.11% 14,263 +64% 0% $222,788
ALLIANCEBERNSTEIN L.P. 0.1% 13,070 0% 0% $204,153
AMERICAN CENTURY COMPANIES INC 0.1% 12,850 +28% 0% $200,717

Institutional Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,742,667 $58,484,802 +$19,804,484 $15.62 68
2025 Q3 2,357,754 $56,965,413 +$23,004,291 $24.16 60
2025 Q2 1,387,298 $49,914,163 +$34,081,287 $35.98 46
2025 Q1 473,835 $8,469,550 +$8,375,403 $17.88 24
2024 Q4 5,377 $1,773 +$1,773 $0.33 2